Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn what to include in your monthly budget checklist to ensure you cover all necessary expenses. Take control of your financial planning.
17,310 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A new lawsuit alleges a former Apple engineer leveraged a bug to access internal files after joining OpenAI, promptin...
As of mid-July 2026, XRP navigates a choppy crypto landscape. AI-driven ripple price predictions: asked assessments p...
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
Memory chips sit at the heart of AI infrastructure. As demand climbs, investors ask if will memory giants micron can ...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
The FHFA want to remove reputational harm as a trigger for suspending firms dealing with Fannie Mae, Freddie Mac, and...
An insider sale at AGCO raises questions about the agricultural machinery cycle. This article breaks down what what t...
BWET, the Breakwave Tanker Shipping ETF, has surged more than 1,000% year-to-date, defying AI-focused bets. The move...
Investors in YMAX face layered fees from a fund-of-funds structure. With a 1.33% expense ratio on top of underlying E...
With American Express set to report on July 24, analysts say a durable franchise, disciplined capital returns, and a ...
NVIDIA continues to outpace AMD in data-center AI hardware even as a Kyber rack delay looms, reinforcing Nvidia’s moa...